GL検索 v0.1.0
画像は 76 ページを描画したものです
page 76

p.76 抽出テキスト

tion and heart failure: a meta-analysis of randomized controlled trials. Europace 2023; 25: 341-350. PMID: 36305545 279. Şaylık F, Çınar T, Akbulut T, et al. Comparison of catheter ablation and medical therapy for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials. Heart Lung 2023; 57: 69-74. PMID: 36084398 280. Parkash R, Wells GA, Rouleau J, et al. Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial. Circulation 2022; 145: 1693-1704. PMID: 35313733 281. Kuck KH, Merkely B, Zahn R, et al. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial. Circ Arrhythm Electrophysiol 2019; 12: e007731. PMID: 31760819 282. Packer DL, Piccini JP, Monahan KH, et al. CABANA Investigators. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation 2021; 143: 1377- 1390. PMID: 33554614 283. Marrouche NF, Brachmann J, Andresen D, et al. CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018; 378: 417-427. PMID: 29385358 284. Prabhu S, Taylor AJ, Costello BT, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol 2017; 70: 1949- 1961. PMID: 28855115 285. Di Biase L, Mohanty P, Mohanty S, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation 2016; 133: 1637-1644. PMID: 27029350 286. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol 2014; 7: 31-38. PMID: 24382410 287. Jones DG, Haldar SK, Hussain W, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 2013; 61: 1894-1903. PMID: 23500267 288. Zakeri R, Ahluwalia N, Tindale A, et al. ARC-HF and CAMTAF Investigators. Long-term outcomes following catheter ablation versus medical therapy in patients with persistent atrial fibrillation and heart failure with reduced ejection fraction. Eur J Heart Fail 2023; 25: 77-86. PMID: 36221809 289. Sugumar H, Prabhu S, Costello B, et al. Catheter ablation versus medication in atrial fibrillation and systolic dysfunction: late outcomes of CAMERA-MRI study. JACC Clin Electrophysiol 2020; 6: 1721-1731. PMID: 33334453 290. Prabhu S, Costello BT, Taylor AJ, et al. Regression of diffuse ventricular fibrosis following restoration of sinus rhythm with catheter ablation in patients with atrial fibrillation and systolic dysfunction: a substudy of the CAMERA MRI trial. JACC Clin Electrophysiol 2018; 4: 999-1007. PMID: 30139501 291. Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy. Heart 2017; 103: 1543- 1552. PMID: 28855272 292. Raymond-Paquin A, Nattel S, Wakili R, et al. Mechanisms and clinical significance of arrhythmia-induced cardiomyopathy. Can J Cardiol 2018; 34: 1449-1460. PMID: 30404750 293. Brembilla-Perrot B, Ferreira JP, Manenti V, et al. Predictors and prognostic significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation. Eur J Heart Fail 2016; 18: 394-401. PMID: 26833591 294. Sohns C, Fox H, Marrouche NF, et al. CASTLE HTx Investigators. Catheter ablation in end-stage heart failure with atrial fibrillation. N Engl J Med 2023; 389: 1380-1389. PMID: 37634135 295. Johner N, Namdar M, Shah DC. Safety, Efficacy and prognostic benefit of atrial fibrillation ablation in heart failure with preserved ejection fraction. Arrhythm Electrophysiol Rev 2022; 11: e 18. PMID: 36304203 296. Aldaas OM, Lupercio F, Darden D, et al. Meta-analysis of the usefulness of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. Am J Cardiol 2021; 142: 66-73. PMID: 33290688 297. Gu G, Wu J, Gao X, et al. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: a meta-analysis. Clin Cardiol 2022; 45: 786-793. PMID: 35544952 298. Chieng D, Sugumar H, Segan L, et al. Atrial fibrillation ablation for heart failure with preserved ejection fraction: a randomized controlled trial. JACC Heart Fail 2023; 11: 646- 658. PMID: 36868916 299. Hosseini SM, Rozen G, Saleh A, et al. Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013. JACC Clin Electrophysiol 2017; 3: 1240- 1248. PMID: 29759619 300. Yokoyama Y, Miyamoto K, Nakai M, et al. Complications associated with catheter ablation in patients with atrial fibrillation: a report from the JROAD-DPC study. J Am Heart Assoc 2021; 10: e019701. PMID: 34041920 301. Raeisi-Giglou P, Wazni OM, Saliba WI, et al. Outcomes and management of patients with severe pulmonary vein stenosis from prior atrial fibrillation ablation. Circ Arrhythm Electrophysiol 2018; 11: e006001. PMID: 29752377 302. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32- 38. PMID: 19995881 303. Packer DL, Keelan P, Munger TM, et al. Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation. Circulation 2005; 111: 546-554. PMID: 15699274 304. Holmes DR Jr, Monahan KH, Packer D. Pulmonary vein stenosis complicating ablation for atrial fibrillation: clinical spectrum and interventional considerations. JACC Cardiovasc Interv 2009; 2: 267-276. PMID: 19463436 305. Ogawa T, Yamashita S, Oseto H, et al. Pulmonary vein angioplasty for pulmonary vein stenosis after ablation therapy for atrial fibrillation ― a report of 7 cases. Circ J 2022; 86: 1229- 1236. PMID: 35786690 306. Almakadma AH, Sarma D, Hassett L, et al. Pulmonary vein stenosisballoon angioplasty versus stenting: a systematic review and meta-analysis. JACC Clin Electrophysiol 2022; 8: 1323- 1333. PMID: 36117046 307. Prieto LR, Schoenhagen P, Arruda MJ, et al. Comparison of stent versus balloon angioplasty for pulmonary vein stenosis complicating pulmonary vein isolation. J Cardiovasc Electrophysiol 2008; 19: 673-678. PMID: 18284494 308. Li YJ, Pan X, Wang C, et al. Stent implantation for severe pulmonary vein stenosis or occlusion secondary to atrial fibrillation ablation. Int J Cardiol 2020; 301: 85-89. PMID: 31813682 309. Fender EA, Widmer RJ, Hodge DO, et al. Severe pulmonary vein stenosis resulting from ablation for atrial fibrillation: presentation, management, and clinical outcomes. Circulation 2016; 134: 1812- 1821. PMID: 27793993 310. Schoene K, Sommer P, Arya A, et al. Complex cases of acquired pulmonary vein stenosis after radiofrequency ablation: is surgical repair an option? Europace 2019; 21: 73-79. PMID: 29444219 310a. Ramirez FD, Reddy VY, Viswanathan R, et al. Emerging technologies for pulmonary vein isolation. Circ Res 2020; 127: 170- 183. PMID: 32716722 310b. Reddy VY, Neuzil P, Koruth JS, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 2019; 74: 315-326. PMID: 31085321 310c. Reddy VY, Dukkipati SR, Neuzil P, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol 2021; 7: 614-627. PMID: 33933412 311. Verma A, Haines DE, Boersma LV, et al. PULSED AF Investigators. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF Pivotal trial. Circulation 2023; 147: 1422- 1432. PMID: 36877118 312. Duytschaever M, De Potter T, Grimaldi M, et al. inspIRE Trial Investigators. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE Study. Circ Arrhythm Electrophysiol 2023; 16: e011780. PMID: 36735937 313. Reddy VY, Gerstenfeld EP, Natale A, et al. ADVENT Investigators. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med 2023; 389: 1660-1671. PMID: 37634148 314. Koruth JS, Kuroki K, Kawamura I, et al. Pulsed field ablation versus radiofrequency ablation: esophageal injury in a novel porcine model. Circ Arrhythm Electrophysiol 2020; 13: e008303. PMID: 31977250 315. van Driel VJ, Neven K, van Wessel H, et al. Low vulnerability of the right phrenic nerve to electroporation ablation. Heart Rhythm 2015; 12: 1838-1844. PMID: 25998897 316. Pansera F, Bordignon S, Bologna F, et al. Catheter ablation induced phrenic nerve palsy by pulsed field ablation-completely impossible? A case series. Eur Heart J Case Rep 2022; 6: ytac361. PMID: 36128440